Lymphoma Research Foundation To Host Hundreds at Philadelphia Patient Workshop

PHILADELPHIA (April 22, 2016) – The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services – is set to host its Lymphoma Workshop: Understanding Lymphoma Basics and Current Treatment Options on May 7, 2016 at the Sheraton Philadelphia Downtown Hotel in Philadelphia, Pennsylvania.

The all-day event, offered free of charge to patients and their caregivers, is slated to bring together more than a dozen prominent lymphoma researchers and clinicians to provide attendees with the latest information about lymphoma and CLL, current treatment options and support issues to members of the lymphoma community across the United States. Co-chaired by Richard I. Fisher, MD, President and CEO of the Fox Chase Cancer Center and Stephen J. Schuster, MD, Director of the Lymphoma Program at the Hospital of the University of Pennsylvania, the Philadelphia Lymphoma Workshop is the premier patient education and networking forum in the region.

Richard I. Fisher, MD, event co-chair“Today’s rapid developments in treatment options demand a comprehensive forum in which patients and their loved ones can come learn directly from the experts on the cutting edge of these advancements,” said Dr. Fisher. “The Fox Chase Cancer Center is proud to partner with the Lymphoma Research Foundation to bring the latest in patient education to those who need it most.”

The Lymphoma Research Foundation’s Lymphoma Workshops Program is designed to enable patients to learn about their specific type of lymphoma, treatment options, clinical trials and support services, and have their specific questions answered from an expert speaking faculty comprised of lymphoma specialists and patient support experts. Attendees also have the opportunity to meet other people with their same type of lymphoma.

“Patient education lies at the center of the Lymphoma Research Foundation’s mission to eradicate lymphoma and serve those touched by this blood cancer,” said Meghan Gutierrez, LRF Chief Executive Officer. “The Lymphoma Research Foundation is proud to provide patients and their loved ones with a first-in-class program like the Philadelphia Lymphoma Workshop, in order to empower them to provide the information needed to make informed decisions regarding their care.”

To learn more or to register for the Lymphoma Research Foundation’s Philadelphia Lymphoma Workshops, visit www.lymphoma.org/PAworkshop2016.

About the Lymphoma Research Foundation

The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization devoted to funding innovative research and serving the lymphoma community through a comprehensive series of education programs, outreach initiatives and patient services. To date, LRF has awarded more than $58 million in lymphoma-specific research. For additional information on LRF’s research, education and services, visit lymphoma.org.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427

Resize Text